Motor Unit Abnormalities After Experimentally Induced Sensitization

NCT04361149 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Central Sensitisation
Motor Disorders

Interventions

DRUG: Capsaicin Topical Cream (0.075%)
DEVICE: Delsys Trigno Galileo System
DEVICE: Excaliber, Natus Medical
OTHER: Placebo Cream

Sponsor

Toronto Rehabilitation Institute